Oncoantigen
Results: 3
| # | Item |
|---|---|
1 | Shionogi Enters into Exclusive Licensing Agreement with OncoTherapy Science to Develop and Market Cancer Peptide Vaccines Osaka, Japan, March 30, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao TesAdd to Reading ListSource URL: shionogi616.tew-staging.comLanguage: English |
2 | PDF DocumentAdd to Reading ListSource URL: www.capconcorp.comLanguage: English - Date: 2014-12-04 10:38:20 |
3 | De Giovanni et al. Breast Cancer Research 2014, 16:R10 http://breast-cancer-research.com/content/16/1/R10Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |